- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04985630
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
July 21, 2023 updated by: Amazentis SA
Open-labelled Study to Validate Home-based Use of a Health and Wellness Kit (The Mitopure Challenge) to Detect Levels of Urolithin A in Dried Blood Spots After Intake of Mitopure (Proprietary Urolithin A)
Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Julie Faitg, PhD
- Phone Number: +41215521272
- Email: jfaitg@amazentis.com
Study Locations
-
-
California
-
San Francisco, California, United States, 94111
- Recruiting
- Amazentis USA
-
Contact:
- Anurag Singh, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Males and females 18 to 80 years of age;
- Is in general good health, as determined by the research team;
- Willingness to consume the investigation product, complete questionnaires and to complete the study;
- Have given voluntary, electronic, informed consent to be a participant in the study.
Exclusion Criteria:
- Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;
- Volunteers who plan to donate blood during the study or within 30 days of completing the study;
- Subject has a known allergy to the test material's active or inactive ingredients;
- Subjects with unstable medical conditions;
- Participation in a clinical research trial within 30 days prior to randomization;
- Allergy or sensitivity to study ingredients;
- Individuals who are cognitively impaired and/or who are unable to give informed consent;
- Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject;
- Has taken antibiotics within the previous 30 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake
Mitopure challenge with diet (Pomegranate juice- Before) followed by Mitopure supplementation (After) to compare levels in blood spots of UA-Glucuronide (in ng/mL)
|
Fruit flavored sachet containing fixed dose of Mitopure™ (Proprietary Urolithin A)
100% Pomegranate juice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Failure/rejection rate (% of the samples) collected at home by participants.
Time Frame: 4 weeks
|
Acceptability target goal is to hit 80% of analyzed samples
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sensitivity and specificity (% of the samples) of the analytical method developed to test Urolithin A in dry blood spots.
Time Frame: 4 weeks
|
4 weeks
|
Fold change increase in the levels of UA-Glucuronide (in ng/mL) in the dried blood spots provided in the kit before and after the challenge
Time Frame: 4 weeks
|
4 weeks
|
Validation of a health questionnaire on participants health status
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anurag Singh, MD, PhD, Amazentis SA
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2021
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
August 31, 2024
Study Registration Dates
First Submitted
July 13, 2021
First Submitted That Met QC Criteria
July 21, 2021
First Posted (Actual)
August 2, 2021
Study Record Updates
Last Update Posted (Estimated)
July 24, 2023
Last Update Submitted That Met QC Criteria
July 21, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 21.02.AMZ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Mitopure
-
Amazentis SAKGK Science Inc.CompletedOverweight | Healthy Aging | Muscle Function, Mitochondrial FunctionCanada
-
Amazentis SAPrinceton Research CorporationCompletedIrritation/Irritant | SensitisationUnited Kingdom
-
Amazentis SAUniversity of Washington; Synteract, Inc.CompletedAging | Muscle Function | Mitochondrial Function, BioenergeticsUnited States
-
Amazentis SAEurofins OptimedCompletedAging | Muscle Function | Mitochondrial DysfunctionFrance
-
Amazentis SAAustralian Catholic UniversityCompleted
-
Amazentis SAGoethe UniversityActive, not recruiting
-
Amazentis SAMprex Healthcare Pvt. Ltd.Not yet recruiting
-
McGill University Health Centre/Research Institute...Amazentis SARecruiting
-
Amazentis SAAtlantia Food Clinical TrialsCompletedHealthy | Healthy AgingUnited States
-
National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States